Author | Thomas Powles, MD | OncLive

Author | Thomas Powles, MD

Articles

Dr. Powles on the Impact of Immunotherapy in Kidney Cancer

November 19, 2017

Video

Thomas Powles, MD, Barts Cancer Institute, discusses the impact of immunotherapy on the treatment landscape of kidney cancer.

Dr. Powles on Bevacizumab Plus Atezolizumab in Kidney Cancer

July 19, 2017

Video

Thomas Powles, MD, Barts Cancer Institute, discusses the combination of bevacizumab (Avastin) and atezolizumab (Tecentriq) versus single-agent atezolizumab versus sunitinib (Sutent), which was studied in the randomized, phase II IMmotion150 trial for patients with metastatic renal cell carcinoma (RCC).

Dr. Powles Discusses the Future of Durvalumab in Bladder Cancer

March 08, 2017

Video

Thomas Powles, MD, Barts Cancer Institute, discusses the future of durvalumab in the treatment of bladder cancer.

Dr. Powles on Durvalumab in Urothelial Cancer

February 20, 2017

Video

Thomas Powles, MD, Barts Cancer Institute, discusses durvalumab as a second-line therapy in locally advanced and metastatic urothelial cancer.

x